Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

Novel Pyrimidines as Antitubercular Agents.

Inoyama D, Paget SD, Russo R, Kandasamy S, Kumar P, Singleton E, Occi J, Tuckman M, Zimmerman MD, Ho HP, Perryman AL, Dartois V, Connell N, Freundlich JS.

Antimicrob Agents Chemother. 2018 Feb 23;62(3). pii: e02063-17. doi: 10.1128/AAC.02063-17. Print 2018 Mar.

2.

In vitro activity of tigecycline against patient isolates collected during phase 3 clinical trials for diabetic foot infections.

Petersen PJ, Ruzin A, Tuckman M, Jones CH.

Diagn Microbiol Infect Dis. 2010 Apr;66(4):407-18. doi: 10.1016/j.diagmicrobio.2009.11.009.

PMID:
20226331
3.

Identification of CTX-M beta-lactamases in Escherichia coli from hospitalized patients and residents of long-term care facilities.

Urban C, Mariano N, Bradford PA, Tuckman M, Segal-Maurer S, Wehbeh W, Grenner L, Colon-Urban R, Johnston B, Johnson JR, Rahal JJ.

Diagn Microbiol Infect Dis. 2010 Apr;66(4):402-6. doi: 10.1016/j.diagmicrobio.2009.11.012.

PMID:
20226330
4.

In vitro activity of tigecycline against patient isolates collected during phase 3 clinical trials for hospital acquired pneumonia.

Petersen PJ, Tuckman M, Jones CH.

Infect Dis Rep. 2010 Feb 2;2(1):e1. doi: 10.4081/idr.2010.e1. eCollection 2010 Feb 3. Review.

5.
6.
7.

In vitro activity of tigecycline and occurrence of tetracycline resistance determinants in isolates from patients enrolled in phase 3 clinical trials for community-acquired pneumonia.

Bradford PA, Petersen PJ, Tuckman M, Jones CH.

Clin Microbiol Infect. 2008 Sep;14(9):882-6. doi: 10.1111/j.1469-0691.2008.02063.x.

8.

Carbapenem-resistant Escherichia coli harboring Klebsiella pneumoniae carbapenemase beta-lactamases associated with long-term care facilities.

Urban C, Bradford PA, Tuckman M, Segal-Maurer S, Wehbeh W, Grenner L, Colon-Urban R, Mariano N, Rahal JJ.

Clin Infect Dis. 2008 Jun 1;46(11):e127-30. doi: 10.1086/588048.

PMID:
18419424
9.

Occurrence of tetracycline resistance genes among Escherichia coli isolates from the phase 3 clinical trials for tigecycline.

Tuckman M, Petersen PJ, Howe AY, Orlowski M, Mullen S, Chan K, Bradford PA, Jones CH.

Antimicrob Agents Chemother. 2007 Sep;51(9):3205-11. Epub 2007 Jul 9.

10.
12.

Use of structure-based drug design approaches to obtain novel anthranilic acid acyl carrier protein synthase inhibitors.

Joseph-McCarthy D, Parris K, Huang A, Failli A, Quagliato D, Dushin EG, Novikova E, Severina E, Tuckman M, Petersen PJ, Dean C, Fritz CC, Meshulam T, DeCenzo M, Dick L, McFadyen IJ, Somers WS, Lovering F, Gilbert AM.

J Med Chem. 2005 Dec 15;48(25):7960-9.

PMID:
16335920
13.

Combinatorial synthesis of substituted 3-(2-indolyl)piperidines and 2-phenyl indoles as inhibitors of ZipA-FtsZ interaction.

Jennings LD, Foreman KW, Rush TS 3rd, Tsao DH, Mosyak L, Kincaid SL, Sukhdeo MN, Sutherland AG, Ding W, Kenny CH, Sabus CL, Liu H, Dushin EG, Moghazeh SL, Labthavikul P, Petersen PJ, Tuckman M, Haney SA, Ruzin AV.

Bioorg Med Chem. 2004 Oct 1;12(19):5115-31. Erratum in: Bioorg Med Chem. 2005 Oct 15;13(20):5884. Haney, Steven A [added].

PMID:
15351395
14.

Design and synthesis of indolo[2,3-a]quinolizin-7-one inhibitors of the ZipA-FtsZ interaction.

Jennings LD, Foreman KW, Rush TS 3rd, Tsao DH, Mosyak L, Li Y, Sukhdeo MN, Ding W, Dushin EG, Kenny CH, Moghazeh SL, Petersen PJ, Ruzin AV, Tuckman M, Sutherland AG.

Bioorg Med Chem Lett. 2004 Mar 22;14(6):1427-31.

PMID:
15006376
15.
16.

Identification and analysis of bacterial protein secretion inhibitors utilizing a SecA-LacZ reporter fusion system.

Alksne LE, Burgio P, Hu W, Feld B, Singh MP, Tuckman M, Petersen PJ, Labthavikul P, McGlynn M, Barbieri L, McDonald L, Bradford P, Dushin RG, Rothstein D, Projan SJ.

Antimicrob Agents Chemother. 2000 Jun;44(6):1418-27.

17.

Mutations in the tetA(B) gene that cause a change in substrate specificity of the tetracycline efflux pump.

Guay GG, Tuckman M, Rothstein DM.

Antimicrob Agents Chemother. 1994 Apr;38(4):857-60.

18.

An assay to detect inhibitors of bacterial iron transport.

Tuckman MK, Chopra I, Osburne MS.

J Antibiot (Tokyo). 1994 Jan;47(1):123-5. No abstract available.

20.

The tet(K) gene from Staphylococcus aureus mediates the transport of potassium in Escherichia coli.

Guay GG, Tuckman M, McNicholas P, Rothstein DM.

J Bacteriol. 1993 Aug;175(15):4927-9.

21.
22.

Mycobacteriophage vector systems.

Jacobs WR Jr, Snapper SB, Tuckman M, Bloom BR.

Rev Infect Dis. 1989 Mar-Apr;11 Suppl 2:S404-10. Review.

PMID:
2652256
23.

Introduction of foreign DNA into mycobacteria using a shuttle phasmid.

Jacobs WR Jr, Tuckman M, Bloom BR.

Nature. 1987 Jun 11-17;327(6122):532-5.

PMID:
3473289
24.

The dental school and the dental graduate, a mutual dependence.

Tuckman MA.

Dialog Fairleigh Dickinson Univ Sch Dent. 1976 Winter;8(1):2-5. No abstract available.

PMID:
1088265
25.

Effect of topical vancomycin on plaque and chronic gingival inflammation.

Kaslick RS, Tuckman MA, Chasens AI.

J Periodontol. 1973 Jun;44(6):366-8. No abstract available.

PMID:
4575464
26.

Investigation of periodontosis with periodontitis: literature survey and findings based on ABO blood groups.

Kaslick RS, Chasens AI, Tuckman MA, Kaufman B.

J Periodontol. 1971 Jul;42(7):420-7. Review. No abstract available.

PMID:
4997033
27.

The relationship of glucose tolerance to periodontal status.

Tuckman MA, Kaslick RS, Shapiro WB, Chasens AI.

J Periodontol. 1970 Sep;41(9):513-9. No abstract available.

PMID:
5271940
28.

The successful management of necrotizing ulcerative gingivitis in the armed forces.

TUCKMAN MA.

Mil Surg. 1953 Jul;113(1):35-9. No abstract available.

PMID:
13063135

Supplemental Content

Loading ...
Support Center